The in vitro detection revealed that both mRNA and protein levels of FADS2 and HMGCR were generally increased in bladder cancer cells as compared with normal cells, which was consistent with our analyses from public TCGA and GEO datasets. The gene discussed is FADS2; the disease is urinary bladder cancer.